Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation: A randomized, double-blind, placebo-controlled, crossover, 32-week study

OBJECTIVE: Because many patients with diabetic macular edema (DME) do not respond to focal/grid laser photocoagulation, the only currently approved treatment, alternatives are needed. Based on encouraging preliminary findings, we aimed to assess efficacy and safety of the anti–tumor necrosis factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sfikakis, Petros P., Grigoropoulos, Vlassis, Emfietzoglou, Ioannis, Theodossiadis, George, Tentolouris, Nicholas, Delicha, Evi, Katsiari, Christina, Alexiadou, Kleopatra, Hatziagelaki, Erifili, Theodossiadis, Panayiotis G.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890353/
https://www.ncbi.nlm.nih.gov/pubmed/20413522
http://dx.doi.org/10.2337/dc09-2372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890353/
https://www.ncbi.nlm.nih.gov/pubmed/20413522
http://dx.doi.org/10.2337/dc09-2372

Ejemplares similares